GANSID Congress brings global experts to Hyderabad to advance care for inherited blood disorders
Delegates from 23 countries joined Indian healthcare professionals and patient organisations to discuss prevention, diagnosis and care for people with inherited blood disorders.
Held at the Hyderabad International Convention Centre–Novotel in Madhapur, the congress provided a platform to exchange scientific knowledge, share experiences and discuss access to healthcare for patients and their families.
HYDERABAD: More than 70 international delegates from 23 countries participated in the fourth GANSID Congress in Hyderabad from October 23 to 25, bringing together medical experts, researchers, policymakers and patient organisations to discuss sickle cell disease, thalassemia and other inherited blood disorders.
The Global Action Network for Sickle Cell and Other Inherited Blood Disorders (GANSID), which organised the congress with the Thalassemia and Sickle Cell Society (TSCS), Hyderabad, said the three-day event focused on strengthening cooperation in prevention, early diagnosis, treatment and long-term patient care.
Held at the Hyderabad International Convention Centre–Novotel in Madhapur, the congress provided a platform to exchange scientific knowledge, share experiences and discuss access to healthcare for patients and their families.
Retired IAS officer Vinod K. Agrawal attended the inaugural ceremony as chief guest. Other participants included Vinita Srivastava of the National Health Authority, Government of India; Dr. Pankaj Gupta of Pfizer India; congress co-chairs Dr. Dipty Jain and Dr. Jameela Sather; and TSCS chief executive officer Dr. Suman Jain.
GANSID chief executive officer Lanre Tunji-Ajayi moderated the inaugural session. Welcoming delegates, she highlighted the need to bring healthcare professionals, researchers, policymakers and patient organisations together to address the challenges associated with inherited blood disorders.
Tunji-Ajayi said participation from 23 countries, alongside delegates from across India, reflected a shared interest in improving diagnosis, treatment and care. Discussions also addressed the medical and social challenges faced by people living with these conditions.
TSCS, the congress’s local partner, said it supports more than 4,800 patients affected by thalassemia, sickle cell disease and other inherited blood disorders. Its activities include blood transfusion support, awareness and prevention programmes, antenatal screening, patient counselling and financial assistance for bone marrow transplantation.
The society said its collaboration with GANSID aimed to strengthen international cooperation, expand public awareness and support the exchange of medical knowledge to improve access to healthcare services.
